GlassScriptPhysician profile
Peter Frandsen Vandyck
NPI 1669537197
$615.30
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $20.77.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $170.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $83.10 | 2019 | |
| Dexcom, INC. | $72.17 | 2019 | |
| Medtronic Minimed, INC. | $33.47 | 2019 | |
| Abbvie INC. | $31.35 | 2019 | |
| Corcept Therapeutics | $26.62 | 2019 | |
| Aytu Biopharma, INC. | $24.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.77 | 2020 | |
| Ibsa Pharma INC. | $18.38 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.25 | 2019 | |
| Eisai INC. | $17.06 | 2019 | |
| Insulet Corporation | $16.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.42 | 2019 | |
| Pfizer INC. | $15.27 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $14.63 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.32 | 2019 | |
| Amneal Pharmaceuticals LLC | $12.82 | 2019 | |
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Vandyck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.